Treventis attends RESI Partnering Week 2021

For the first time in several years, Treventis CEO Christopher Barden attended the Redefining Early Stage Investments (RESI) conference (held virtually this year due to COVID-19). This conference is a prominent event for life sciences and medical technology companies looking to raise funds for the next stage of their company development. Treventis was proud to schedule meetings with nearly a dozen investors and organizations with interest in neurodegenerative drug development.

Share this page

Facebook
Twitter
LinkedIn
Email
#pf-body .pf-caption img.blockImage { margin: 0!important; float: none; } #pf-body a.elementor-icon, #pf-body a.skip-link{display:none!important;} /*#pf-content img.pf-large-image {max-width:100%!important}*/ #pf-content img.mediumImage, #pf-content figure.mediumImage { margin-left: auto!important; margin-right: auto!important; clear: both!important; float: none!important; display: block!important; }